Adiponectin exerts pleiotropic actions in various organs, i.e., it promotes insulin sensitivity, and apoptosis in cancer cells, primarily through its anti-inflammatory, anti-atherogenic, and insulin-sensitizing effects. The gene discussed is ADIPOQ; the disease is cancer.